Bharat Biotech’s Covaxin gets nod for emergency use in children from 12 to 18 years of age

Bharat Biotech’s COVID-19 vaccine ‘Covaxin’ has received approval for Emergency use in children between 12 to 18 years of age. In a statement, Bharat Biotech said, Covaxin is formulated uniquely such that the same dosage can be administered to adults and children.

It said, Covaxin has established a proven record for safety and efficacy in adults for the original variant and subsequent variants.

The company said it has documented excellent safety and immunogenicity data readouts in children. The company said it looks forward for Covaxin to provide for similar levels of protections for adults and children alike.

It thanked the Health Ministry, NITI Aayog, Drug Controller General of India and India’s National Technical Advisory Group on Immunisation-NTAGI for their diligent review of all data and for their fastidious approval process.



Leave a Reply

Your email address will not be published.

fifteen + three =

News is information about current events. News is provided through many different media: word of mouth, printing, postal systems, broadcasting, electronic communication, and also on the testimony of observers and witnesses to events. It is also used as a platform to manufacture opinion for the population.

Contact Info

D 601  Riddhi Sidhi CHSL
Unnant Nagar Road 2
Kamaraj Nagar, Goreagaon West
Mumbai 400062 .

Email Id: [email protected]

West Bengal

Eastern Regional Office
Indsamachar Digital Media
Siddha Gibson 1,
Gibson Lane, 1st floor, R. No. 114,
Kolkata – 700069.
West Bengal.

Office Address

251 B-Wing,First Floor,
Orchard Corporate Park, Royal Palms,
Arey Road, Goreagon East,
Mumbai – 400065.

Download Our Mobile App

IndSamachar Android App IndSamachar IOS App
To Top
WhatsApp WhatsApp us